Cited by 4,984Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSingle-cell and spatial transcriptomicsTransplantation: Methods and Outcomes

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; none of the 26 sources its claims cite is checked for support yet.

Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage

Open access

Published version of a preprint

Abstract

Tissue fibrosis is a major cause of mortality that results from the deposition of matrix proteins by an activated mesenchyme. Macrophages accumulate in fibrosis, but the role of specific subgroups in supporting fibrogenesis has not been investigated in vivo. Here, we used single-cell RNA sequencing (scRNA-seq) to characterize the heterogeneity of macrophages in bleomycin-induced lung fibrosis in mice. A novel computational framework for the annotation of scRNA-seq by reference to bulk transcriptomes (SingleR) enabled the subclustering of macrophages and revealed a disease-associated subgroup with a transitional gene expression profile intermediate between monocyte-derived and alveolar macrophages. These CX3CR1+SiglecF+ transitional macrophages localized to the fibrotic niche and had a profibrotic effect in vivo. Human orthologs of genes expressed by the transitional macrophages were upregulated in samples from patients with idiopathic pulmonary fibrosis. Thus, we have identified a pathological subgroup of transitional macrophages that are required for the fibrotic response to injury. Using scRNA-seq analysis, Bhattacharya and colleagues identify a subset of profibrotic lung macrophages that have a gene expression signature intermediate between those of monocytes and alveolar macrophages.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41590-018-0276-y

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

30 Own result · 20 Own interpretation · 12 Not checked yet · 10 Own method · 3 No basis given

Verify all 26 references — free account
  • It may state two separate claims as one. 19
  • Probably not a substantial claim. 14
  • The quote only partly states this claim. 1
29 of 29
  • The paper relies on this without support.

    The bleomycin-induced mouse lung fibrosis model recapitulates key features of human lung fibrosis, so findings in it can inform human disease.

    “Our observation that ablation of macrophages expressing Cx3cr1 decreased fibroblasts and lung collagen content after bleomycin treatment has relevance for human disease.”
  • The paper relies on this without support.

    The 3T3 embryonic mouse fibroblast cell line is a valid proxy for lung fibroblasts in fibrosis for assessing migration and proliferation.

    “we performed in vitro assays with 3T3 fibroblasts, an embryonic mouse fibroblast cell line.”
  • The paper relies on this without support.

    The Pdgf-aa blocking antibody specifically neutralizes Pdgf-aa without affecting other PDGF isoforms or unrelated pathways.

    “Antibody blockade of Pdgf-aa inhibited the enhanced gap closure seen in SiglecF+CD11c+MHCIIhi compared to SiglecF+CD11c+MHCIIlo conditioned media”
  • The paper relies on this without support.

    Changes in expression of human orthologues in bulk lung microarray samples reflect changes in macrophage populations rather than other cell types.

    “we performed single-sample gene set enrichment analysis (ssGSEA)31 to quantify the expression of human orthologues of genes of interest in a published microarray dataset of 167 lung samples from patients with lung fibrosis and 50 healthy controls32”
  • The paper relies on this without support.

    The human lung explants with regional heterogeneity are representative of idiopathic pulmonary fibrosis fibrotic foci.

    “In three lung explants displaying such regional heterogeneity, we found that PDGF-AA+ macrophages were associated with the fibrotic rather than non-fibrotic regions”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Cited by

Sorted by citations

See all 4,984

Metadata

Authors
Aran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., Butte, A. J., & Bhattacharya, M.
Affiliations
  • University of California, San Francisco (US)
  • Gladstone Institutes (US)
  • QB3 (US)
Corresponding author
Bhattacharya, Mallar
Venue
Nature Immunology
Published
2019-01-14
Volume
20
Issue
2
Pages
163-172
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W2907514116
Cited by
4,984
References
56
Citations by year
2026: 831 · 2025: 1024 · 2024: 966 · 2023: 856 · 2022: 662 · 2021: 394 · 2020: 181 · 2019: 63
FWCI
249.29
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Immunology (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Gladstone Institutes
  • National Institutes of Health (HHSN272201200028C)
  • University of California, San Francisco
  • National Heart, Lung, and Blood Institute (L30 HL110167, R01HL131560, R01HL139897)
  • National Institute of Allergy and Infectious Diseases (HHSN272201200028C)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
pulmonary fibrosis, macrophage heterogeneity, bleomycin-induced lung fibrosis, idiopathic pulmonary fibrosis, monocyte-derived macrophages, alveolar macrophages, CX3CR1, fibrotic niche, macrophage activation
MeSH terms
CX3C Chemokine Receptor 1, Animals, Bleomycin, Cells, Cultured, Disease Models, Animal, Female, Humans, Lung, Macrophage Activation, Male, Antigens, Differentiation, Myelomonocytic, Up-Regulation, Macrophages, Alveolar, Sequence Analysis, RNA, Gene Expression Profiling, Mice, Idiopathic Pulmonary Fibrosis, Single-Cell Analysis, Sialic Acid Binding Immunoglobulin-like Lectins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review